Company profile for SunRock Biopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

SunRock Biopharma transforms academic knowledge into therapeutic solutions through a disruptive open-innovation methodology. The core activity of the company lies in the development of innovative antibodies against highly invasive tumors with an urgent clinical need in oncology.SunRock Biopharma strives to become a worldwide key agent in immunotherapy for oncology, through identification, development and transfer of academic k...
SunRock Biopharma transforms academic knowledge into therapeutic solutions through a disruptive open-innovation methodology. The core activity of the company lies in the development of innovative antibodies against highly invasive tumors with an urgent clinical need in oncology.SunRock Biopharma strives to become a worldwide key agent in immunotherapy for oncology, through identification, development and transfer of academic knowledge to the pharmaceutical industry.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Spain
Address
Address
Edificio Emprendia, P2-S-01 2nd floor Campus Vida s/n, Santiago de Compostela,...
Telephone
Telephone
+34 881 975 523
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-10-20/sunrock-biopharma-and-chime-biologics-announce-strategic-collaboration-to-advance-development-of-ant

PHARMIWEB
20 Oct 2025

https://www.businesswire.com/news/home/20250930083824/en/Debiopharm-Licenses-SunRock-Biopharmas-Anti-HER3HER2-Antibody-to-Explore-the-Full-Potential-of-Bispecific-ADC-Debio-2512

BUSINESSWIRE
30 Sep 2025

https://www.businesswire.com/news/home/20250617760732/en/SunRock-Biopharma-and-Escugen-Forge-Alliance-to-Develop-First-in-Class-CCR9-Targeted-ADC

BUSINESSWIRE
17 Jun 2025

https://www.businesswire.com/news/home/20240108143318/en

BUSINESSWIRE
08 Jan 2024

https://www.businesswire.com/news/home/20230920230991/en

BUSINESSWIRE
21 Sep 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty